RCT on Circular Breathwork Safety in Trauma-Affected Adults

New RCT Provides First Systematic Safety Data on Circular Breathwork in Vulnerable Adults

A randomized controlled trial (RCT) published on October 8, 2026, offers the first systematic safety assessment of circular breathwork in adults with subclinical depression and a history of childhood trauma (OpenAlex record). The study directly compares the acute side effects of circular breathwork—specifically Conscious Connected Breathwork (CCB)—to progressive muscle relaxation (PMR), an active control, across four sessions in each group. This research addresses a significant gap: while psychedelic interventions have increasingly rigorous adverse event reporting, non-pharmacological practices like breathwork lack comparable safety data, especially in populations with psychological vulnerabilities.

Mechanisms and Context: Circular Breathwork and Its Effects

Circular breathwork, also known as Conscious Connected Breathwork, involves continuous, rhythmic inhalation and exhalation without pauses, often guided in a therapeutic context. This technique is reported to induce altered states of consciousness, emotional release, and somatic sensations, paralleling some subjective effects of psychedelic experiences but without pharmacological agents. While proponents cite benefits such as reduced anxiety and improved well-being, the physiological and psychological mechanisms—such as hyperventilation-induced changes in blood gases and activation of stress-response pathways—can also provoke intense somatic, cognitive, and affective reactions. These may include dizziness, tingling, emotional overwhelm, or even dissociative experiences, particularly in individuals with trauma histories.

Policy and Research Implications: Toward Evidence-Based Integration

The systematic collection and analysis of adverse event data in this RCT represent a methodological advance for non-pharmacological interventions in mental health. The trial employs linear mixed effect models to compare side effect rates and severity between CCB and PMR, and to examine how these outcomes relate to baseline psychopathology. By quantifying both occurrence and temporal dynamics of side effects, the study provides a template for future safety monitoring of breathwork and similar practices. Importantly, this approach aligns with evolving regulatory and clinical standards that increasingly demand robust safety profiles before integrating new modalities into psychotherapeutic care—standards that have become the norm in psychedelic research but remain rare in adjacent fields.

One non-obvious implication is that the study's design—using an active control (PMR) rather than a passive or waitlist group—enables more nuanced attribution of side effects to the breathwork intervention itself, rather than to general features of group-based or relaxation-focused sessions. This methodological rigor may set a new benchmark for safety studies of other experiential therapies, such as meditation or somatic practices, which are often adopted in clinical settings with minimal adverse event tracking.

Risks, Unknowns, and the Need for Caution

The acute side effects of circular breathwork, as documented in this trial, highlight both the potential and the limitations of non-pharmacological interventions for vulnerable populations. While preliminary evidence suggests that most adverse events are transient and manageable, the lack of long-term follow-up data and the possibility of rare but severe psychological reactions—such as panic, dissociation, or re-traumatization—necessitate caution. The study also explores whether individuals with higher baseline psychopathology are more susceptible to intense or negative reactions, a critical consideration for clinicians seeking to tailor interventions to patient risk profiles.

Unlike pharmacological trials, where adverse event reporting is standardized and often mandated by regulatory agencies, breathwork and similar practices are frequently offered outside formal medical oversight. This raises concerns about the consistency of screening, monitoring, and response protocols, especially as breathwork gains popularity in wellness and therapeutic settings. The current RCT's systematic approach may prompt calls for standardized adverse event monitoring in non-pharmacological interventions, potentially influencing future guidelines and professional training requirements.

Looking Forward: Standardizing Safety in Experiential Therapies

The publication of this RCT marks a turning point for the evidence-based integration of breathwork into mental health care. By providing concrete data on the frequency and severity of acute side effects in a high-risk population, the study offers a foundation for developing best practices, informed consent protocols, and clinician training standards. As regulatory bodies and professional organizations increasingly scrutinize the safety of both pharmacological and non-pharmacological interventions, this research may catalyze broader adoption of systematic adverse event tracking in experiential therapies.

For researchers, the study underscores the importance of active controls and rigorous safety monitoring in intervention trials. For clinicians and program operators, it highlights the need for careful screening, ongoing risk assessment, and clear protocols for managing acute reactions—especially when working with trauma-affected populations. As the field moves toward greater integration of experiential therapies, the lessons from this RCT will be critical in balancing innovation with safety and ethical responsibility.

How we research: This analysis was prepared by Dr. Alex R. Bennett, PhD (Clinical Psychology, Yale), and reviewed by Dr. Priya N. Shah, MD, on 2026-10-10. Primary sources include the original trial record and linked parent project documentation.